3-hydroxi-anthranilic acid is early expressed in stroke

Area of Science:

• Neuroscience
• Biochemistry
• Pathology

Background:

• 3-hydroxy-anthranilic acid (3-HAA) is a metabolite with known cytotoxic effects.
• Its presence and role in the mammalian brain, particularly under pathological conditions, remain largely uncharacterized.

Purpose of the Study:

• To investigate the distribution of 3-HAA in the rat brain following an induced stroke.
• To determine if 3-HAA is localized in specific brain regions or cell types after ischemic injury.

Main Methods:

• Development of a monoclonal antibody against 3-HAA.
• Application of immunohistochemical techniques in control and stroke-induced rat models (transient middle cerebral artery occlusion).
• Double immunohistochemistry to identify cell types expressing 3-HAA.

Main Results:

• 3-HAA immunoreactivity was exclusively detected in the infarcted areas (ipsilateral striatum/cerebral cortex) 2, 5, and 21 days post-stroke.
• No 3-HAA was observed in control rats or the contralateral hemisphere of stroke animals.
• 3-HAA was found to coexist with glial fibrillary acidic protein (GFAP) in astrocytes within the infarcted regions.

Conclusions:

• This study reports for the first time the presence of 3-HAA in the mammalian brain under pathological stroke conditions.
• The localization of 3-HAA within infarcted brain tissue suggests its potential involvement in stroke-induced tissue damage due to its cytotoxic properties.